Chao Han, PhD (he/him/his)

VP of Early Development
Tavotek Biotherapeutics

Poster(s):

• (M1030-10-65) Clinical Correlation of Conventional Allometric Scaling Approach for PK Predictions of FcRn Enhanced and Protease Resistant Long-Acting mAbs, TAVO101 and TAVO103
  Monday, October 23, 2023

  10:30 AM – 11:30 AM ET

• (T1530-10-63) Prediction of Human PK for Multispecific Antibody TAVO412 Using Non-linear Population PK Model and Allometric Scaling
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET